长链非编码RNA-UCA1对膀胱癌诊断价值的Meta分析

摘要
图/表
参考文献(22)
相关文章 (15)

全文: PDF (932 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的通过Meta分析系统性评价长链非编码RNA尿路上皮癌相关1基因（lncRNA-UCA1）对膀胱癌的诊断价值。方法检索PubMed、Web of Science、EMBASE、CNKI、万方、维普等数据库，收集lncRNA-UCA1用于膀胱癌诊断的相关文献，起止时间为建库至2018年7月31日。根据纳入与排除标准筛选文献、提取资料；应用QUADAS-2条目工具评价文献质量，采用Meta-Disc 1.4和Stata 12.0软件进行统计分析，合并UCA1用于膀胱癌诊断的统计量。结果共纳入6篇文献，其共含膀胱癌患者919例，非癌对照418例。lncRNA-UCA1用于区分膀胱癌和非癌对照的合并敏感度为0.78（95%CI：0.76~0.80），特异度为0.87（95%CI：0.85~0.90），曲线下面积（AUC）为0.93。亚组分析结果显示，基于GAPDH为内参的lncRNA-UCA1检测效能（AUC：0.98）高于非GAPDH（AUC：0.85）；以尿液为检测基质的lncRNA-UCA1分析具有较高的诊断效能（敏感度：0.78；特异度：0.86；AUC：0.93）。结论 lncRNA-UCA1对膀胱癌有较高的临床辅助诊断价值。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	罗晓莉* 肖燕萍* 林颖烽* 崔兆磊陈燕

关键词 ：长链非编码RNA, 尿路上皮癌相关1基因, 膀胱癌, 诊断, Meta分析

Abstract：Objective To systematically evaluate the diagnostic value of long-chain non-coding RNA urothelial carcinoma associated gene 1 (lncRNA-UCA1) for bladder cancer by meta-analysis. Methods PubMed, Web of Science, EMBASE, CNKI, Wanfang and VIP databases were retrieved. Literatures related to the use of lncRNA-UCA1 in the diagnosis of bladder cancer were collected, starting from the establishment of the database until July 31, 2018. According to inclusion and exclusion criteria, literatures were screened and data were extracted; QUADAS-2 item tool was used to evaluate the quality of literature, Meta-Disc 1.4 and Stata 12.0 software were used for statistical analysis, and statistics on UCA1 for the diagnosis of bladder cancer were combined. Results A total of 6 articles were included, including 919 cases of bladder cancer and 418 cases of non-cancer control. The combined sensitivity of lncRNA-UCA1 was 0.78 (95% CI: 0.76-0.80), specificity was 0.87 (95% CI: 0.85-0.90), and area under curve (AUC) was 0.93. Subgroup analysis showed that the detection efficiency of lncRNA-UCA1 based on GAPDH as internal reference (AUC: 0.98) was higher than that of non-GAPDH (AUC: 0.85); the detection efficiency of lncRNA-UCA1 based on urine as detection matrix was higher (sensitivity: 0.78; specificity: 0.86; AUC: 0.93). Conclusion lncRNA-UCA1 has high clinical value in the diagnosis of bladder cancer.

Key words： Long-chain non-coding RNA Urothelial cancer-related gene 1 Bladder cancer Diagnosis Meta-analysis

基金资助:国家临床重点专科建设项目（2013）；
福建省医学创新课题（2016-CX-9）。

通讯作者: 陈燕（1963-），女，教授，硕士生导师，主任医师，主要从事肿瘤实验诊断的基础和临床研究。

作者简介: *共同第一作者

引用本文:

罗晓莉* 肖燕萍* 林颖烽* 崔兆磊陈燕. 长链非编码RNA-UCA1对膀胱癌诊断价值的Meta分析[J]. 中国医药导报, 2019, 16(11): 77-80,84.
LUO Xiaoli* XIAO Yanping* LIN Yingfeng* CUI Zhaolei CHEN Yan. Meta-analysis of the value of long-chain non-coding RNA-UCA1 in the diagnosis of bladder cancer. 中国医药导报, 2019, 16(11): 77-80,84.

链接本文:

http://www.yiyaodaobao.com.cn/CN/ 或 http://www.yiyaodaobao.com.cn/CN/Y2019/V16/I11/77

[1] Chee KG，Cambio A，Lara PN. Recent developments in advanced urothelial cancer [J]. Curr Opin Urol，2005，15（5）：342-349.
[2] Kamat AM，Hegarty PK，Gee JR，et al. ICUD-EAU International Consultation on Bladder Cancer 2012：screening，diagnosis，and molecular markers [J]. Eur Urol，2013，63（1）：4-15.
[3] Milowich D，Le Mercier M，De Neve N，et al. Diagnostic value of the UCA1 test for bladder cancer detection：a clinical study [J]. Springerplus，2015，4：349.
[4] Eissa S，Matboli M，Essawy NO，et al. Rapid detection of urinary long non-coding RNA urothelial carcinoma associated one using a PCR-free nanoparticle-based assay [J]. Biomarkers，2015，20（3）：212-217.
[5] Eissa S，Matboli M，Essawy NO，et al. Integrative functional genetic-epigenetic approach for selecting genes as urine biomarkers for bladder cancer diagnosis [J]. Tumour Biol，2015，36（12）：9545-9552.
[6] Srivastava AK，Singh PK，Rath SK，et al. Appraisal of diagnostic ability of UCA1 as a biomarker of carcinoma of the urinary bladder [J]. Tumour Biol，2014，35（11）：11 435-11 442.
[7] 张争，郝瀚，张崔建，等.新基因uca1用于膀胱癌诊断的临床应用价值[J].中华医学杂志，2012，92（6）：384-387.
[8] Wang XS，Zhang Z，Wang HC，et al. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma [J]. Clin Cancer Res，2006，12（16）：4851-4858.
[9] Bots S，Nylund K，L?觟wenberg M，et al. Ultrasound for Assessing Disease Activity in IBD Patients：A Systematic Review of Activity Scores [J]. J Crohns Colitis，2018，12（8）：920-929.
[10] Ebell MH，Culp MB，Radke TJ. A Systematic Review of Symptoms for the Diagnosis of Ovarian Cancer [J]. Am J Prev Med，2016，50（3）：384-394.
[11] Higgins JP，Thompson SG，Deeks JJ，et al. Measuring inconsistency in meta-analyses [J]. BMJ，2003，327（7414）：557-560.
[12] Dinnes J，Deeks J，Kirby J，Roderick P. A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy [J]. Health Technol Assess，2005，9（12）：1-113.
[13] Deeks JJ，Macaskill P，Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed [J]. J Clin Epidemiol，2005，58（9）：882-893.
[14] Mukherjee N，Cardenas E，Bedroll R，et al. SETD6 regulates NF-kappaB signaling in urothelial cell survival：Implications for bladder cancer [J]. Oncotarget，2017，8（9）：15 114-15 125.
[15] Lu J，Zheng X，Li F，et al. Tunneling nanotubes promote intercellular mitochondria transfer followed by increased invasiveness in bladder cancer cells [J]. Oncotarget，2017， 8（9）：15 539-15 552.
[16] Segovia C，Martínez-Fernández M，Due?觡as M，et al. Opposing roles of PIK3CA gene alterations to EZH2 signaling in non-muscle invasive bladder cancer [J]. Oncotarget，2017，8（6）：10 531-10 542.
[17] Kamat AM，Hahn NM， Efstathiou JA，et al. Bladder cancer [J]. Lancet，2016，388 （10 061）：2796-2810.
[18] Olivieri M，Ferro M，Terreri S，et al. Long noncoding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis [J]. Oncotarget，2016，7（5）：20 636-20 654.
[19] Leeflang MM，Deeks JJ，Gatsonis C，et al. Systematic reviews of diagnostic test accuracy [J]. Ann Intern Med，2008，149（12）：889-897.
[20] Xiao Z，Peng W，Zhou X，et al. Abnormally expressed microRNA as auxiliary biomarkers for nasopharyngeal carcinoma：A meta-analysis [J]. Biomed Rep，2018，8（1）：99-105.
[21] Chen Y，Xiao Z，Hu M，et al. Diagnostic efficacy of long non-coding RNA MALAT-1 in human cancers：a meta-analysis study [J]. Oncotarget，2017，8（60）：102 291-102 300.
[22] Cui Z，Chen Y，Xiao Z，et al. Long noncoding RNAs as auxiliary biomarkers for gastric cancer screening：A pooled analysis of individual studies [J]. Oncotarget，2016， 7（18）：25 791-25 800.